✦ LIBER ✦

757 OUTCOME OF PEGINTERFERON ALFA-2B AND RIBAVIRIN THERAPY FOLLOWING MP-424 (TELAPREVIR) MONOTHERAPY FOR 24 WEEKS IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

✍ Scribed by O. Itaru

Book ID: 117378841
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 51 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60759-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v

746 NARLAPREVIR AND PEGINTERFERON ALFA-2

746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS

✍ J. de Bruijne; J.F. Bergmann; C.J. Weegink; R. Molenkamp; J. Schinkel; M.A. Trei 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy of 24 weeks treatment with pegi

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

✍ Stefan Zeuzem; Maria Buti; Peter Ferenci; Jan Sperl; Yves Horsmans; Janusz Cianc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A MP-424 FOR 24 WEEKS IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

✍ I. Ozeki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Peginterferon alfa-2b plus weight-based

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response

✍ A. Craxi; S. Koutsounas; P. Ogurtsov; L. Chemello; M. Maticic; J. Torras; M. Dia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Rapid loss of hepatitis C virus genotype

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks

✍ Fumitaka Suzuki; Norio Akuta; Yoshiyuki Suzuki; Hitomi Sezaki; Hiromi Yatsuji; Y 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB